Kwality Pharmaceuticals Ltd (KPL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,127.10",
    "chg": 128.55,
    "chgp": "6.43%",
    "dir": 1,
    "prev_price": "1,998.55",
    "mcapval": "2,207.12 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539997,
    "symbol": "KPL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE552U01010",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "1.98 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "RP",
      "url": "https://www.marketsmojo.com/mojopro/strategy/3",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-4000678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_mojoScore_4000678.png",
        "date": "2026-05-20 10:10:56",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 2194.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs21944-4000523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_4000523.png",
        "date": "2026-05-20 09:40:27",
        "description": "From a 52-week low of Rs 810.5 to a fresh high of Rs 2194.4 on 20 May 2026, Kwality Pharmaceuticals Ltd has more than doubled in value over the past year, delivering a remarkable 123.07% return. This surge comes amid a backdrop of mixed market conditions, with the Sensex trading below its 50-day moving average and hovering near its own 52-week low."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 2,194.4 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-record-high-of-rs-219440-on-20-may-2026-4000490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_4000490.png",
        "date": "2026-05-20 09:32:28",
        "description": ""
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-reports-very-positive-quarterly-financial-performance-amid-strong-market-returns-3999993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_fintrenddot_3999993.png",
        "date": "2026-05-20 08:00:20",
        "description": "Kwality Pharmaceuticals Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, shifting from an outstanding to a very positive financial trend. This robust quarterly showing is complemented by impressive stock returns that have significantly outpaced the broader Sensex index over multiple time horizons."
      },
      {
        "title": "Kwality Pharmaceuticals Q4 FY26: Strong Finish with 75% Profit Surge Powers Stellar Year",
        "link": "https://www.marketsmojo.com/news/result-analysis/kwality-pharmaceuticals-q4-fy26-strong-finish-with-75-profit-surge-powers-stellar-year-3999867",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_quaterlyResult_3999867.png",
        "date": "2026-05-19 21:03:38",
        "description": "Kwality Pharmaceuticals Ltd., the Amritsar-based pharmaceutical manufacturer, delivered an exceptional fourth quarter performance for FY26, posting consolidated net profit of ₹25.30 crores—a remarkable 74.60% surge year-on-year and 58.03% jump quarter-on-quarter. The ₹1,954 crore market cap company concluded the fiscal year with revenue of ₹157.11 crores in Q4 FY26, marking its strongest quarterly performance yet and cementing a year of robust operational momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1920",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1920-3998584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_3998584.png",
        "date": "2026-05-19 09:40:42",
        "description": "Surging to an intraday peak of Rs 1920 on 19 May 2026, Kwality Pharmaceuticals Ltd has marked a significant milestone by hitting a new 52-week and all-time high. This rally, driven by a confluence of robust technical signals and sustained price momentum, underscores the stock’s impressive performance over the past year, outpacing the broader market by a wide margin."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 1891.4 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-at-rs-18914-3998548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_priceRelatedfactors_3998548.png",
        "date": "2026-05-19 09:32:59",
        "description": "Extending its winning streak to five consecutive sessions, Kwality Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1891.4 on 19 May 2026, outperforming its sector and the broader market with notable volatility and strong volume support."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-attractiveness-3997867",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_valuationdot_3997867.png",
        "date": "2026-05-19 08:02:16",
        "description": "Kwality Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive category, reflecting a significant change in price attractiveness. This transition, coupled with robust financial metrics and strong market performance, positions the micro-cap pharmaceutical firm as a compelling buy in the current market environment."
      },
      {
        "title": "125% Stock Return, 64.5% Profit Growth: What's Driving Kwality Pharmaceuticals Ltd's Multibagger Rerating?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-a-multibagger-stock-defying-market-trends-with-exceptional-returns-3996454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KwalityPharmace_multibagger_3996454.png",
        "date": "2026-05-18 09:50:26",
        "description": "A 125.07% stock return in one year. A 64.5% growth in net profit over the same period. The gap between those two numbers — roughly 60 percentage points — is driven largely by the market's willingness to pay more for each rupee of Kwality Pharmaceuticals Ltd's earnings. That willingness is the story behind this micro-cap's multibagger status."
      }
    ],
    "total": 287,
    "sid": "1002639",
    "stock_news_url": "https://www.marketsmojo.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "14-May-2026",
      "details": "Intimation of Analysts/Investors Conference Call to be held on May 19 2026 at 5:00 P.M. to discuss Q4 FY26 financial results.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026",
      "datetime": "08-May-2026",
      "details": "Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve the Standalone & Consolidated Audited Financial Results for the 4th Quarter and Financial Year Ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "08-May-2026",
      "details": "Intimation of Revision in Credit Rating",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kwality Pharmaceuticals Ltd is Rated Buy

2026-05-20 10:10:56

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 2194.4

2026-05-20 09:40:27

From a 52-week low of Rs 810.5 to a fresh high of Rs 2194.4 on 20 May 2026, Kwality Pharmaceuticals Ltd has more than doubled in value over the past year, delivering a remarkable 123.07% return. This surge comes amid a backdrop of mixed market conditions, with the Sensex trading below its 50-day moving average and hovering near its own 52-week low.

Read full news article

Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 2,194.4 as Momentum Builds Across Timeframes

2026-05-20 09:32:28

Read full news article

Kwality Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance Amid Strong Market Returns

2026-05-20 08:00:20

Kwality Pharmaceuticals Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, shifting from an outstanding to a very positive financial trend. This robust quarterly showing is complemented by impressive stock returns that have significantly outpaced the broader Sensex index over multiple time horizons.

Read full news article

Kwality Pharmaceuticals Q4 FY26: Strong Finish with 75% Profit Surge Powers Stellar Year

2026-05-19 21:03:38

Kwality Pharmaceuticals Ltd., the Amritsar-based pharmaceutical manufacturer, delivered an exceptional fourth quarter performance for FY26, posting consolidated net profit of ₹25.30 crores—a remarkable 74.60% surge year-on-year and 58.03% jump quarter-on-quarter. The ₹1,954 crore market cap company concluded the fiscal year with revenue of ₹157.11 crores in Q4 FY26, marking its strongest quarterly performance yet and cementing a year of robust operational momentum.

Read full news article

Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 1920

2026-05-19 09:40:42

Surging to an intraday peak of Rs 1920 on 19 May 2026, Kwality Pharmaceuticals Ltd has marked a significant milestone by hitting a new 52-week and all-time high. This rally, driven by a confluence of robust technical signals and sustained price momentum, underscores the stock’s impressive performance over the past year, outpacing the broader market by a wide margin.

Read full news article

Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 1891.4 as Momentum Builds Across Timeframes

2026-05-19 09:32:59

Extending its winning streak to five consecutive sessions, Kwality Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1891.4 on 19 May 2026, outperforming its sector and the broader market with notable volatility and strong volume support.

Read full news article

Kwality Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Attractiveness

2026-05-19 08:02:16

Kwality Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive category, reflecting a significant change in price attractiveness. This transition, coupled with robust financial metrics and strong market performance, positions the micro-cap pharmaceutical firm as a compelling buy in the current market environment.

Read full news article

125% Stock Return, 64.5% Profit Growth: What's Driving Kwality Pharmaceuticals Ltd's Multibagger Rerating?

2026-05-18 09:50:26

A 125.07% stock return in one year. A 64.5% growth in net profit over the same period. The gap between those two numbers — roughly 60 percentage points — is driven largely by the market's willingness to pay more for each rupee of Kwality Pharmaceuticals Ltd's earnings. That willingness is the story behind this micro-cap's multibagger status.

Read full news article

View All News